Search results
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 16 hours agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 15 hours agoLong term investing can be life changing when you buy and hold the truly great businesses. And we've...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 13 hours agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 23 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 13 hours agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 16 hours agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoModerna (NASDAQ: MRNA) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 18 hours agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.